A. Ciarlo
Impact in
- Hepatology top 5%
- Hepatocellular Carcinoma Treatment and Prognosis
- Oncology top 10%
- Colorectal Cancer Treatments and Studies
- Cancer Treatment and Pharmacology
- Pancreatic and Hepatic Oncology Research
Papers in
- Oncology 11
- Colorectal Cancer Treatments and Studies 10
- Cancer Treatment and Pharmacology 10
- HER2/EGFR in Cancer Research 1
-
- Gastric Cancer Management and Outcomes 9
- Metastasis and carcinoma case studies 3
- Co-authors
- Alfredo Falcone (10 shared papers)Fotios Loupakis (8 shared papers)Gianluca Masi (8 shared papers)D. Amoroso (4 shared papers)Lisa Salvatore (5 shared papers)Francesca Del Monte (2 shared papers)Gabriella Fontanini (2 shared papers)M. Andreuccetti (3 shared papers)
In The Last Decade
A. Ciarlo
16 papers receiving 365 citations
Peers
Comparison fields: 5 of 42
- Hepatology 144
- Oncology 301
- Pulmonary and Respiratory Medicine 119
- Pathology and Forensic Medicine 58
- Cancer Research 45
Countries citing papers authored by A. Ciarlo
This map shows the geographic impact of A. Ciarlo's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by A. Ciarlo with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites A. Ciarlo more than expected).
Fields of papers citing papers by A. Ciarlo
This network shows the impact of papers produced by A. Ciarlo. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by A. Ciarlo. The network helps show where A. Ciarlo may publish in the future.
Co-authors
The 25 scholars most cited alongside A. Ciarlo, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2010 | 190 | |
| 2 | 2014 | 60 | |
| 3 | 2012 | 50 | |
| 4 | 2008 | 17 | |
| 5 | 2015 | 15 | |
| 6 | 2012 | 10 | |
| 7 | 2004 | 7 | |
| 8 | 2012 | 5 | |
| 9 | 2022 | 4 | |
| 10 | 2009 | 3 | |
| 11 | Phase II study of first-line treatment in metastatic colorectal cancer (MCRC) with GONO-FOLFOXIRI (Irinotecan, Oxaliplatin and Infusional 5FU/LV) plus Bevacizumab | 2008 | 3 |
| 12 | First-line treatment of metastatic colorectal cancer (MCRC) with folfoxiri (irinotecan, oxaliplatin and infusional 5FU/LV) in combination with bevacizumab (BV): A phase II study by the G.O.N.O. Group | 2008 | 2 |
| 13 | Bevacizumab (BV) in combination with folfoxiri (Irinotecan, Oxaliplatin and Infusional 5FU/LV) as first-line treatment of metastatic colorectal cancer (mCRC): a phase II trial by the GONO GROUP | 2009 | 2 |
| 14 | 2009 | 2 | |
| 15 | ITACA-S (Intergroup trial of adjuvant chemotherapy in adenocarcinoma of the stomach) trial: comparison of a sequential treatment versus a 5-FU/LV regimen for radically resecate gastric cancer. Tolerability and feasibility of a randomized study | 2010 | 1 |
| 16 | 2014 | 1 |
About A. Ciarlo
A. Ciarlo is a scholar working on Oncology, Pulmonary and Respiratory Medicine, Hepatology, Gastroenterology and Surgery, having authored 16 papers that have together received 372 indexed citations. Recurring topics across this work include Colorectal Cancer Treatments and Studies (10 papers), Cancer Treatment and Pharmacology (10 papers), Gastric Cancer Management and Outcomes (9 papers), Hepatocellular Carcinoma Treatment and Prognosis (5 papers), Gastrointestinal Tumor Research and Treatment (4 papers), Metastasis and carcinoma case studies (3 papers), Breast Cancer Treatment Studies (1 paper) and HER2/EGFR in Cancer Research (1 paper). The work is most often cited by research in Hepatology (144 citations), Oncology (301 citations), Pulmonary and Respiratory Medicine (119 citations), Pathology and Forensic Medicine (58 citations) and Cancer Research (45 citations). A. Ciarlo has collaborated with scholars based in Italy and Canada. Frequent co-authors include Alfredo Falcone, Fotios Loupakis, Gianluca Masi, D. Amoroso, Lisa Salvatore, Francesca Del Monte, Gabriella Fontanini, M. Andreuccetti, Elisa Sensi and Samanta Cupini. Their work appears in journals such as Journal of Clinical Oncology, Annals of Oncology, The Lancet Oncology, European Journal of Cancer and Gastric Cancer.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.